MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer. - Wikidata - wikimedia - TriplyDB

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.

http://www.wikidata.org/entity/Q34984068

about

Tamoxifen Resistance: Emerging Molecular Targets The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients Roles for miRNAs in endocrine resistance in breast cancer The reversal of antineoplastic drug resistance in cancer cells by β-elemene Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer Decoding the usefulness of non-coding RNAs as breast cancer markers MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer Critical analysis of the potential for microRNA biomarkers in breast cancer management.Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.MicroRNA-519a promotes proliferation and inhibits apoptosis of hepatocellular carcinoma cells by targeting FOXF2.Parsing interindividual drug variability: an emerging role for systems pharmacology.Analysis of factors affecting endocrine therapy resistance in breast cancer.MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.miRNA clusters as therapeutic targets for hormone-resistant breast cancer.MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.The novel role of miRNAs for tamoxifen resistance in human breast cancer.Human and primate-specific microRNAs in cancer: Evolution, and significance in comparison with more distantly-related research models: The great potential of evolutionary young microRNA in cancer research.MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells MicroRNA profiles involved in trifluridine resistance.Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking.MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management.microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers

P2860

Q26739969-86A84C16-69F9-4FFA-98DC-5A3743DBDC69 Q26782449-DB002CB1-0629-49B4-B251-0654E4FCA453 Q26783076-07E82634-9ADA-4240-95C6-00EAB8AE2C9F Q26787004-CAA80223-A711-442F-931B-89351C31A034 Q27011221-E2B88A63-EF22-4D79-8F26-79BD526A6B0A Q28066481-85FF3353-E582-43DC-A07D-2AD2C9C0C71E Q28069370-C891268E-F0CF-4C2C-851E-FD8FFE36BCF2 Q35128098-070C0C68-BF6A-49D8-844A-A15355D824F6 Q35137273-91433BF8-0D12-4BD9-B997-0581FAC86F9C Q35709636-B41A1ACA-FB8C-4860-8589-E8EC2961D661 Q35912303-6CF93638-D718-4361-A2CA-7D583BDF0D87 Q35930811-9F65ECCC-C828-4E50-89E3-AA32DFD1885E Q35932634-A1BCB066-52D1-454C-AD23-69A00D1BC910 Q36320426-760638C3-45CE-4074-A63A-7A97DE43DE65 Q36417380-8C995217-AA32-441A-BA01-087C0752934F Q36502389-4067011E-E4F0-42DA-92A5-B053127BAC55 Q36571466-467E03BD-A03B-4809-9783-38EE8BDC9496 Q36808390-590E78C5-4A3E-4719-A702-BCCC3A8B9A5F Q36992190-6E6A8FE2-0DAE-4662-99CB-0EA8A9E63B5F Q37236236-CB8E9AD4-D7AF-47BE-9A96-C12C3149BA27 Q37316805-EB3BAE2E-A79A-4F89-809B-5120D7BF7E43 Q37641578-CA67BE73-5885-4BCE-A43E-EC06E0515800 Q38381678-CDF62B42-3F75-4BC1-932A-97F808E47D4B Q38708204-251FDAAC-96FA-4321-B4E3-FF0CBC0B26D7 Q38904555-DAECC63D-BEE3-45EC-B998-8AC21DF8FD8F Q40245310-7D8C8C82-E1DC-4591-A468-62FD375DACAC Q41169679-D434F051-B27B-4FA8-983A-2D7071C9322B Q41593018-B107A748-F851-4EFC-829A-D11C228C0F8F Q47730656-EFBCBF1A-4C84-4102-82C1-343D2ED78538 Q48837549-14F734E3-39EB-47D2-A324-E70A3C3FE95C Q49163340-AFD84F2F-266A-46C1-991E-47607D482D70 Q52714385-E540EEF5-5BB6-48A4-B90E-6C6EEFC4773A Q54944098-F6D63CF9-CBCD-464E-B93B-D421C8CCE98D Q57106025-323952CC-4E81-43C1-A575-CCD15BA1DA5A Q58601661-22B196A4-5525-4BEA-A793-93D5ECDF6E9C

P2860

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.

http://www.wikidata.org/entity/Q34984068

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@ast

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@en

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@nl

type

label

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@ast

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@en

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@nl

prefLabel

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@ast

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@en

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@nl

P1433

Q34984068-2E958307-5CDD-4B46-9BBA-38E981DA80F4

P1476

Q34984068-6ED36441-EA33-4E0B-82E8-FEFD8C545906

P2093

Q34984068-00BF7426-2D2B-4DDF-AB7F-2A8F458B89FD

Q34984068-9D056F66-69E6-45CE-863A-1A4CB77F6F2C

Q34984068-DB214E56-0166-4EFE-9626-423D5E323901

P2860

Q34984068-02C30117-BFD7-4C26-B0BB-76C506CC7AB3

Q34984068-15DA4D3C-7F90-4CB1-A3D8-67C339D8A74A

Q34984068-1723979A-742D-464F-8C72-8E8D894067CF

Q34984068-19D4F60F-4F8C-42A8-9E74-66B95FDAFC54

Q34984068-34B4E37F-6517-4E54-9A7E-1B60C388C2CD

Q34984068-386B6188-5B9A-46EB-88EF-952216E7220A

Q34984068-4307C0FF-8439-46D4-8860-286A865D3C24

Q34984068-48AF34A3-70B2-4E13-8235-B4E1AED36492

Q34984068-56124DA1-A787-4446-9BAA-42C72FAA6997

Q34984068-579B97E8-1D84-4159-91FE-887990D72BF5

P304

Q34984068-50F7B2B6-28CF-4963-90CE-F6C4B6CE2672

P31

Q34984068-8E87C6B1-3CAA-4A4F-9A21-26413B5C3447

P356

Q34984068-257FC512-375D-4122-BFFC-CF5AC093AE80

P433

Q34984068-C787B780-EC58-4708-8B6C-E5EC2A7877FA

P478

Q34984068-ABA4B783-8EF2-42B6-8C04-9F229C33076D

P50

Q34984068-4081D637-8E71-452B-9F86-6F7895289ACF

Q34984068-9C591397-4CC5-4FEB-8761-82016DCE616D

Q34984068-9DCCB5FC-2C7E-4949-805F-F11A586C3B63

Q34984068-FA1B4687-DFF0-4F23-8428-0E2446ED9E37

P577

Q34984068-57E8BC36-4431-47AF-A2BC-661C00401930

P5875

Q34984068-ECA25DBA-DF9B-4A9C-9E2A-9F47128F3C05

P698

Q34984068-97E59C30-9A18-419B-A9E2-0E7F1AEAE951

P921

Q34984068-6584E105-FF6F-48A7-B8A6-D9E300193912

P932

Q34984068-30862080-76A9-48CC-A6EB-C2644389BD29

P356

P1433

The Journal of Pathology

P1476

MicroRNA-519a is a novel oncom ...... or genes in ER+ breast cancer.

@en

P2093

Aoife Ward

http://www.w3.org/2001/XMLSchema#string

Ozgür Sahin

http://www.w3.org/2001/XMLSchema#string

Rainer König

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of mammalian microRNA host genes and transcription units

miRBase: integrating microRNA annotation and deep-sequencing data

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

The impact of microRNAs on protein output

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study

P304

368-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4363

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Aleksandra Balwierz

P577

2014-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261771385

http://www.w3.org/2001/XMLSchema#string

P698

24752803

http://www.w3.org/2001/XMLSchema#string

P921

P932

4298809

http://www.w3.org/2001/XMLSchema#string